Additional file 6: of Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses

2015-10-16T05:00:00Z (GMT) by Ola Caster I. Edwards
Definitions of included serious adverse effects. (PDF 111 kb)